Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1505

1.

Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.

Bradbury R, Champion A, Reid DW.

Respirology. 2008 Nov;13(6):886-92. doi: 10.1111/j.1440-1843.2008.01383.x.

PMID:
18811887
2.

Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa.

Tingpej P, Elkins M, Rose B, Hu H, Moriarty C, Manos J, Barras B, Bye P, Harbour C.

Respirology. 2010 Aug;15(6):923-9. doi: 10.1111/j.1440-1843.2010.01792.x. Epub 2010 Jun 21.

PMID:
20573059
3.

Epidemiology of Pseudomonas aeruginosa in a tertiary referral teaching hospital.

Bradbury RS, Champion AC, Reid DW.

J Hosp Infect. 2009 Oct;73(2):151-6. doi: 10.1016/j.jhin.2009.05.021. Epub 2009 Aug 21.

PMID:
19699556
4.

Epidemiology and clinical impact of Pseudomonas aeruginosa infection in cystic fibrosis using AP-PCR fingerprinting.

Adams C, Morris-Quinn M, McConnell F, West J, Lucey B, Shortt C, Cryan B, Watson JB, O'Gara F.

J Infect. 1998 Sep;37(2):151-8.

PMID:
9821090
5.

Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units.

O'Carroll MR, Syrmis MW, Wainwright CE, Greer RM, Mitchell P, Coulter C, Sloots TP, Nissen MD, Bell SC.

Eur Respir J. 2004 Jul;24(1):101-6.

6.

Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.

Mahenthiralingam E, Campbell ME, Foster J, Lam JS, Speert DP.

J Clin Microbiol. 1996 May;34(5):1129-35.

7.

Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland.

Logan C, Habington A, Lennon G, Grogan J, Byrne M, O'Leary J, O'Sullivan N.

J Med Microbiol. 2012 Jan;61(Pt 1):64-70. doi: 10.1099/jmm.0.035642-0. Epub 2011 Sep 15.

PMID:
21921114
8.

Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation.

Edenborough FP, Stone HR, Kelly SJ, Zadik P, Doherty CJ, Govan JR.

J Cyst Fibros. 2004 Mar;3(1):37-44.

9.

PCR-based detection of a cystic fibrosis epidemic strain of Pseudomonas Aeruginosa.

Panagea S, Winstanley C, Parsons YN, Walshaw MJ, Ledson MJ, Hart CA.

Mol Diagn. 2003;7(3-4):195-200.

PMID:
15068391
10.

High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic.

Vosahlikova S, Drevinek P, Cinek O, Pohunek P, Maixnerova M, Urbaskova P, van den Reijden TJ, Dijkshoorn L, Nemec A.

Res Microbiol. 2007 May;158(4):324-9. Epub 2007 Mar 3.

PMID:
17448645
11.

Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time PCR and high-resolution melting curve analysis.

Anuj SN, Whiley DM, Kidd TJ, Ramsay KA, Bell SC, Syrmis MW, Grimwood K, Wainwright CE, Nissen MD, Sloots TP.

Clin Microbiol Infect. 2011 Sep;17(9):1403-8. doi: 10.1111/j.1469-0691.2010.03439.x. Epub 2011 Jan 28.

12.

Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.

Sener B, Köseoğlu O, Ozçelik U, Kocagöz T, Günalp A.

Int J Med Microbiol. 2001 Nov;291(5):387-93.

PMID:
11727823
13.

Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung.

Manos J, Arthur J, Rose B, Tingpej P, Fung C, Curtis M, Webb JS, Hu H, Kjelleberg S, Gorrell MD, Bye P, Harbour C.

J Med Microbiol. 2008 Dec;57(Pt 12):1454-65. doi: 10.1099/jmm.0.2008/005009-0.

PMID:
19018014
14.
15.

Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.

Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R.

Am J Infect Control. 2006 May;34(4):188-92.

PMID:
16679175
16.

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

Oliver A, Cantón R, Campo P, Baquero F, Blázquez J.

Science. 2000 May 19;288(5469):1251-4.

17.

Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients.

Anthony M, Rose B, Pegler MB, Elkins M, Service H, Thamotharampillai K, Watson J, Robinson M, Bye P, Merlino J, Harbour C.

J Clin Microbiol. 2002 Aug;40(8):2772-8.

18.

Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.

Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A; Scandinavian CF Study Consortium (SCFSC)..

J Cyst Fibros. 2009 Mar;8(2):135-42. doi: 10.1016/j.jcf.2008.11.001. Epub 2009 Jan 20.

19.

Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp.

Ojeniyi B, Frederiksen B, Hoiby N.

Pediatr Pulmonol. 2000 Mar;29(3):177-81.

PMID:
10686037
20.

Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008.

Emerson J, McNamara S, Buccat AM, Worrell K, Burns JL.

Pediatr Pulmonol. 2010 Apr;45(4):363-70. doi: 10.1002/ppul.21198.

PMID:
20232473

Supplemental Content

Support Center